Pivotal bioVenture Partners Investment Advisor

Latest statistics and disclosures from Pivotal bioVenture Partners Investment Advisor's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are PCVX, INZY, OCS, ARQT, EXAI, and represent 93.73% of Pivotal bioVenture Partners Investment Advisor's stock portfolio.
  • Added to shares of these 1 stock: ARQT.
  • Reduced shares in these 1 stock: Fusion Pharmaceuticals (-$12M).
  • Sold out of its position in Fusion Pharmaceuticals.
  • Pivotal bioVenture Partners Investment Advisor was a net seller of stock by $-12M.
  • Pivotal bioVenture Partners Investment Advisor has $130M in assets under management (AUM), dropping by -16.40%.
  • Central Index Key (CIK): 0001844645

Tip: Access up to 7 years of quarterly data

Positions held by Pivotal bioVenture Partners Investment Advisor consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Pivotal bioVenture Partners Investment Advisor

Pivotal bioVenture Partners Investment Advisor holds 10 positions in its portfolio as reported in the June 2024 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Vaxcyte (PCVX) 46.0 $60M 793k 75.51
 View chart
Inozyme Pharma (INZY) 15.4 $20M 4.5M 4.46
 View chart
Oculis Holding Ordinary Shares (OCS) 14.7 $19M 1.6M 11.95
 View chart
Arcutis Biotherapeutics (ARQT) 14.6 $19M 2.0M 9.30
 View chart
Exscientia Ads (EXAI) 3.0 $3.9M 771k 5.10
 View chart
Rallybio Corp (RLYB) 2.5 $3.2M 2.4M 1.34
 View chart
Vigil Neuroscience (VIGL) 1.7 $2.2M 561k 4.00
 View chart
Bolt Biotherapeutics (BOLT) 1.1 $1.4M 1.9M 0.75
 View chart
Io Biotech (IOBT) 0.8 $1.0M 864k 1.17
 View chart
Aligos Therapeutics (ALGS) 0.2 $260k 743k 0.35
 View chart

Past Filings by Pivotal bioVenture Partners Investment Advisor

SEC 13F filings are viewable for Pivotal bioVenture Partners Investment Advisor going back to 2020